The 2nd International Symposium on Drugs and Driving was hosted in Wellington to confront the challenges of responding to drug impaired driving.
The two day event provided ademics, policy analysts and lawmakers from around the world to come to terms with the challenges of framing drug driving as a road safety issue. The symposium was held in Wellington, New Zealand 12–13 November 2014.
The Drug Foundation co-hosted the symposium with:
The symposium in Wellington followed an earlier event held in Canada in July 2011.
In March 2011 this concern was recognized by the United Nations Commission on Narcotic Drugs with resolution 54/2, which stressed the importance of a coordinated approach to addressing the health and public safety consequences of drugged driving. In July 2011, CCSA hosted the first International Symposium on Drugs and Driving in partnership with the EMCDDA, the National Institute on Drug Abuse (NIDA), ONDCP, and Public Safety Canada.
The objective of this symposium was to assess new international research, evidence, and practice that have accumulated since 2011, and to identify existing evidence gaps to inform collective road safety efforts. The event was targeted at policy makers, politicians, road safety advocates, researchers, and enforcement officers.
The symposium focused on six key areas: Monitoring and Surveillance; Legislation and Policy; Detection, Deterrence and Enforcement; Adjudication and Sanctions; Health Interventions and Treatment; and Public Awareness, Health Promotion and Prevention.
To address these issues, panels of international experts provided overviews of the situation in their respective countries or regions, as well as the strength of the existing evidence, critical evidence gaps (and possible solutions), recent developments, and future priorities.
The symposium includes a summary of issues addressed, along with a framework for action on drug driving.
A recording of each session is available. Go to the playlist on YouTube or start watching below.
Here's a record of what was shared.
Survey participants also reported that barriers to accessing services, resources and information were high.
A group of powerful synthetic opioids that were first detected in the country just a year ago may have already been linked to several deaths.
95% of respondents reported positive effects, in a study that looked at both prescription and black market cannabis use.